<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:04:06Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5356396" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5356396</identifier><datestamp>2017-03-22</datestamp><setSpec>bmcendi</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="case-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Endocr Disord</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Endocr Disord</journal-id>
      <journal-title-group>
        <journal-title>BMC Endocrine Disorders</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1472-6823</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5356396</article-id>
      <article-id pub-id-type="pmcid">PMC5356396</article-id>
      <article-id pub-id-type="pmc-uid">5356396</article-id>
      <article-id pub-id-type="pmid">28302169</article-id>
      <article-id pub-id-type="publisher-id">164</article-id>
      <article-id pub-id-type="doi">10.1186/s12902-017-0164-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Two novel <italic>LHX3</italic> mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ramzan</surname>
            <given-names>Khushnooda</given-names>
          </name>
          <address>
            <phone>+966 11 4647272</phone>
            <email>kramzan@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bin-Abbas</surname>
            <given-names>Bassam</given-names>
          </name>
          <address>
            <email>benabbas@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Jomaa</surname>
            <given-names>Lolwa</given-names>
          </name>
          <address>
            <email>ljomaah74@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Allam</surname>
            <given-names>Rabab</given-names>
          </name>
          <address>
            <email>rallam@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Al-Owain</surname>
            <given-names>Mohammed</given-names>
          </name>
          <address>
            <email>alowain@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Imtiaz</surname>
            <given-names>Faiqa</given-names>
          </name>
          <address>
            <email>fahmad@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2191 4301</institution-id><institution-id institution-id-type="GRID">grid.415310.2</institution-id><institution>Department of Genetics, </institution><institution>King Faisal Specialist Hospital and Research Centre, </institution></institution-wrap>P.O.Box 3354, Riyadh, 11211 Saudi Arabia </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2191 4301</institution-id><institution-id institution-id-type="GRID">grid.415310.2</institution-id><institution>Department of Pediatrics, </institution><institution>King Faisal Specialist Hospital and Research Centre, </institution></institution-wrap>Riyadh, Saudi Arabia </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2191 4301</institution-id><institution-id institution-id-type="GRID">grid.415310.2</institution-id><institution>Department of Medical Genetics, </institution><institution>King Faisal Specialist Hospital and Research Centre, </institution></institution-wrap>Riyadh, Saudi Arabia </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1758 7207</institution-id><institution-id institution-id-type="GRID">grid.411335.1</institution-id><institution/><institution>College of Medicine, Alfaisal University, </institution></institution-wrap>Riyadh, Saudi Arabia </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>17</volume>
      <elocation-id>17</elocation-id>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© The Author(s). 2017</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Congenital combined pituitary hormone deficiency (CPHD) is a rare heterogeneous group of conditions. CPHD-type 3 (CPHD3; MIM# 221750) is caused by recessive mutations in <italic>LHX3</italic>, a LIM-homeodomain transcription factor gene. The isoforms of LHX3 are critical for pituitary gland formation and specification of the anterior pituitary hormone-secreting cell types. They also play distinct roles in the development of neuroendocrine and auditory systems.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Here, we summarize the clinical, endocrinological, radiological and molecular features of three patients from two unrelated families. Clinical evaluation revealed severe CPHD coupled with cervical vertebral malformations (rigid neck, scoliosis), mild developmental delay and moderate sensorineural hearing loss (SNHL). The patients were diagnosed with CPHD3 based on the array of hormone deficiencies and other associated syndromic symptoms, suggestive of targeted <italic>LHX3</italic> gene sequencing. A novel missense mutation c.437Gâ&gt;âT (p. Cys146Phe) and a novel nonsense mutation c.466Câ&gt;âT (p. Arg156Ter), both in homozygous forms, were found. The altered Cys146 resides in the LIM2 domain of the encoded protein and is a phylogenetically conserved residue, which mediates LHX3 transcription factor binding with a zinc cation. The p. Arg156Ter is predicted to result in a severely truncated protein, lacking the DNA binding homeodomain.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Considering genotype/phenotype correlation, we suggest that the presence of SNHL and limited neck rotation should be considered in the differential diagnosis of CPHD3 to facilitate molecular diagnosis. This report describes the first <italic>LHX3</italic> mutations from Saudi patients and highlights the importance of combining molecular diagnosis with the clinical findings. In addition, it also expands the knowledge of <italic>LHX3</italic>-related CPHD3 phenotype and the allelic spectrum for this gene.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>
          <italic>LHX3</italic>
        </kwd>
        <kwd>Pituitary hormone deficiency</kwd>
        <kwd>Sensorineural hearing loss</kwd>
        <kwd>Cysteine 146</kwd>
        <kwd>Differential diagnosis</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002382</institution-id>
              <institution>King Faisal Specialist Hospital and Research Centre</institution>
            </institution-wrap>
          </funding-source>
          <award-id>RAC#2100001</award-id>
          <principal-award-recipient>
            <name>
              <surname>Imtiaz</surname>
              <given-names>Faiqa</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>King Salman Centre for Disability Research</institution>
          </funding-source>
          <award-id>KSCDR#85722</award-id>
          <principal-award-recipient>
            <name>
              <surname>Imtiaz</surname>
              <given-names>Faiqa</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Combined pituitary hormone deficiency (CPHD) refers to a rare heterogeneous group of conditions, which is characterized by true deficiency of at least two anterior pituitary hormones. CPHD has been linked with abnormalities in the genes encoding both signaling molecules and transcription factors, which have been shown to play a role in the development and maturation of the pituitary gland. These genes include <italic>HESX1</italic>, <italic>LHX3</italic>, <italic>LHX4</italic>, <italic>POU1F1</italic>, <italic>PROP1</italic>, <italic>SIX6</italic>, <italic>OTX2</italic>, <italic>PTX2</italic>, <italic>GLI2</italic> and <italic>SOX3</italic> [<xref ref-type="bibr" rid="CR1">1</xref>â<xref ref-type="bibr" rid="CR3">3</xref>]. The pituitary phenotype caused by genetic defects in these genes may be isolated (pure pituitary phenotype) or may be associated with variable extrapituitary maifestations (syndromic CPHD) [<xref ref-type="bibr" rid="CR4">4</xref>]. Clinical presentation is variable, depending on the type and severity of deficiencies and at the age of diagnosis. If untreated, main symptoms usually include short stature, cognitive alterations or delayed puberty. CPHD is related to significant morbidity, especially hypoglycemia and its consequences in newborns. Treatment should be started immediately and a strict specialized follow-up is necessary [<xref ref-type="bibr" rid="CR5">5</xref>]. Here, we describe the clinical, endocrinological, radiological and molecular features of three new cases of <italic>LHX3</italic>-related CPHD3.</p>
      <p>Mutations in the <italic>LHX3</italic> gene (MIM# 600577), located on chromosome 9q34.3, underlie combined pituitary hormone deficiency type 3 (CPHD3, MIM# 221750). The encoded protein (Uniprot: Q9UBR4) is a LIM-homeodomain (LIM-HD) transcription factor, which features two amino-terminal LIM domains (cysteine-rich zinc-binding domain) and a centrally-located DNA-binding homeodomain [<xref ref-type="bibr" rid="CR6">6</xref>]. In addition, the LHX3 protein also possesses a carboxyl terminus that includes the major trans-activation domain. Alternative splicing generates two isoforms, LHX3a and LHX3b, which are 397 and 402 amino acids long, respectively. These isoforms possess identical LIM domains, homeodomains and carboxyl termini but possess different amino-termini and differentially activate pituitary gene targets [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>Typically, genetically-confirmed CPHD3 patients with homozygous <italic>LHX3</italic> mutations present with hypopituitarism including deficiencies in the growth hormone (GH), thyroid stimulating hormone (TSH), prolactin (PRL), leutinizing hormone (LH), follicular stimulating hormone (FSH) and abnormal pituitary morphology. Adrenocorticotrophic hormone (ACTH) deficiency, cervical abnormalities with or without restricted neck rotation and sensorineural hearing loss (SNHL) has also been reported in a subset of these patients. The phenotypes in three patients (aged 2â11Â year) in this report include CPHD, rigid cervical spine, restricted neck rotation, scoliosis, mild developmental delay and congenital hearing impairment. Targeted sequencing of the <italic>LHX3</italic> gene revealed two novel recessive variants in these patients. Finally, we surveyed the functional consequences of these mutations.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>We ascertained three patients with syndromic symptoms associated with CPHD. An informed written consent was used to recruit the patients and their family members. All affected patients underwent detailed examination at the departments of clinical genetics and pediatrics of King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Laboratory testing, radiological investigation (X-ray) and audiologic assessments were performed. Pituitary examination was made by multisequential multiplanar magnetic resonance imaging (MRI) by applying standard scanning protocols [<xref ref-type="bibr" rid="CR9">9</xref>]. The hormonal tests were measured by radioimmunoassay techniques by Roche Diagnostics, USA. Hormonal evaluation included basal levels for GH response to glucagon stimulation, TSH, PRL, LH, FSH, cortisol, ACTH and free thyroxine (FT4) levels. Growth biochemical markers including insulin growth factor 1 (IGF1) and insulin growth factor binding protein 3 (IGFBP3) were also assessed. The diagnoses of hormonal deficiencies were established using the normal range as cutoff limits: Basal GH (&gt;10Â Î¼g/L), TSH (0.27â4.2Â mU/L), PRL (2.5â15Â Î¼g/L), LH (0.1â3.3 U/L), FSH (0.1â7 U/L), ACTH (5â60Â ng/L), cortisol (190â750Â nmol/L), FT4 (12â22 pmol/L), IGF1 (115â498Â ng/L) and IGFBP3 (0.7â3.6Â mg/L).</p>
      <sec id="Sec3">
        <title>Cases</title>
        <sec id="Sec4">
          <title>Patient 1, Family 1</title>
          <p>This boy (II:2, Fig.Â <xref rid="Fig1" ref-type="fig">1a</xref>) was a product of an uneventful pregnancy and normal vaginal delivery at 39Â weeks of gestation, whose healthy consanguineous parents had previously lost a daughter in infancy probably because of the same condition. At birth, he was noted to have a micropenis with a stretched penile length of 1.8Â cm and undescended testes. Other dysmorphic features included short webbed neck with limited rotation and triangular face. During hypoglycemic attack at the 3<sup>rd</sup> month of the life, ACTH and GH deficiencies were diagnosed. Later TSH and gonadotropin deficiencies were also found (see TableÂ <xref rid="Tab1" ref-type="table">1</xref>). Both TSH and FT4 were low suggesting central hypothyroidism. MRI of pituitary gland showed a small cystic lesion replacing the adenohypophysis of the pituitary gland representing developmental cystic abnormality. The pituitary stalk was present with normally placed neurohypophysis. Skeletal survey showed closure of sagittal suture causing dolichocephaly and hypoplasia of the facial bones. Thyroxine (25Â Î¼g daily), hydrocortisone (2.5Â mg twice daily) and subcutaneous injections for GH (0.035Â mg/kg/day) were initiated to normalize glycemia and to improve somatic growth at the 5<sup>th</sup> month of age. His height was 107Â cm at age of 7Â years (on the 5th percentile, â2SD). Testosterone therapy was given at a dose of 25Â mg monthly for 3Â months, which improved penile length to 3.1Â cm. He also had moderate SNHL at the age of 2Â years.<fig id="Fig1"><label>Fig. 1</label><caption><p>Family pedigrees, genotypes, growth charts for patients and clinical presentation. <bold>a</bold>, <bold>b</bold> Pedigrees of the families studied with CPHD3 demonstrating the recessive inheritance pattern. <italic>Filled symbols</italic> indicate affected individuals. The respective genotype is indicated below each individual. Symbols are: + for wild type allele;âfor mutated allele. <bold>c</bold>, <bold>d</bold>, <bold>e</bold> Representative growth chart for Patients II:2 (Family 1), II:2 (Family 2) and II:4 (Family 2) showing reduced growth velocity for all patients and reduced response for patient 2 and 3 compared to patient 1. Affected patient 2 (II:2 from family 2) showing <bold>f</bold> neck rotation, <bold>g</bold> scoliosis and <bold>h</bold> lower thoracic scoliosis by spine x-ray. <bold>i</bold>, <bold>j</bold> Multisequential multiplanar brain MRI reveals pituitary gland hypoplasia for patient II:2 from family 1 <bold>i</bold> coronal view <bold>j</bold> sagittal view <bold>k</bold> skull x-ray demonstrates an increased anterior-posterior diameter of calvarium suggestive of dolicocephaly</p></caption><graphic xlink:href="12902_2017_164_Fig1_HTML" id="MO1"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical data for three patients with novel <italic>LHX3</italic> mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Patient 1 (II:2, Family 1)</th><th>Patient 2 (II:2, Family 2)</th><th>Patient 3 (II:4, Family 2)</th></tr></thead><tbody><tr><td>Age, years</td><td>7</td><td>11</td><td>2</td></tr><tr><td>Gestational age, weeks</td><td>39</td><td>39</td><td>39</td></tr><tr><td>Birth weight, kg (SD)</td><td>3.2 (0SD)</td><td>3 (â 0.7SD)</td><td>2.9 (â 0.7SD)</td></tr><tr><td>Birth length, cm (SD)</td><td>45 (â2.5SD)</td><td>NA</td><td>46 (â1.8SD)</td></tr><tr><td>Age of onset, months</td><td>3</td><td>2</td><td>2</td></tr><tr><td>Initial manifestation hypopituitarism</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Basal GH Î¼g/L (&gt;10)</td><td>&lt;0.2</td><td>&lt;0.5</td><td>&lt;0.5</td></tr><tr><td>TSH mU/L (0.27â4.2)</td><td>0.02</td><td>0.04</td><td>0.4</td></tr><tr><td>PRL Î¼g/L (2.5â15)</td><td>0.1</td><td>0.1</td><td>NA</td></tr><tr><td>LH U/L (0.1â3.3)</td><td>&lt;0.1</td><td>&lt;0.1</td><td>&lt;0.1</td></tr><tr><td>FSH U/L (0.1â7)</td><td>&lt;0.1</td><td>&lt;0.1</td><td>&lt;0.1</td></tr><tr><td>ACTH ng/L (5â60)</td><td>6</td><td>8</td><td>16</td></tr><tr><td>cortisol nmol/L (190â750)</td><td>70</td><td>62</td><td>102</td></tr><tr><td>FT4 pmol/L (12â22)</td><td>4.4</td><td>9.3</td><td>10.3</td></tr><tr><td>IGF1 ng/L (115â498)</td><td>&lt;25</td><td>&lt;25</td><td>NA</td></tr><tr><td>IGFBP3 mg/L (0.7â3.6)</td><td>&lt;0.5</td><td>&lt;0.3</td><td>NA</td></tr><tr><td>Hypolplastic pituitary gland</td><td>+</td><td>+</td><td>-</td></tr><tr><td>Limited neck rotation</td><td>+</td><td>+</td><td>-</td></tr><tr><td>SNHL</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Developmental delay (Mild)</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Other findings</td><td>Dolichocephaly, Hypolasia of facial bones, frontal bossing, short webbed neck</td><td>Dolichocephaly, Thoracic scoliosis, squint</td><td>None</td></tr><tr><td>Mutation Identified</td><td>c.437Gâ&gt;âT (p. Cys146Phe) Homozygous</td><td colspan="2">c.466Câ&gt;âT (p. Arg156Ter) Homozygous</td></tr><tr><td>Type of mutation</td><td>Missense mutation</td><td colspan="2">Nonsense</td></tr><tr><td>Effect on protein</td><td>Location a well-established domain</td><td colspan="2">Null mutation</td></tr><tr><td>Computation (in silico) predictive analysis</td><td>âDamagingâ</td><td colspan="2">âDamagingâ</td></tr><tr><td>Population data</td><td>Not annotated as polymorphism</td><td colspan="2">Not annotated as polymorphism</td></tr><tr><td>Functional data</td><td>Located in functional domain</td><td colspan="2">Located in functional domain</td></tr><tr><td>Allelic and family segregation data</td><td>Recessive mutation and strong segregation</td><td colspan="2">Recessive mutation and strong segregation</td></tr><tr><td>Other Evidence</td><td>Relevant to patientâs phenotype</td><td colspan="2">Relevant to patientâs phenotype</td></tr><tr><td>Variant classification (ACMG)</td><td>Likely pathogenic</td><td colspan="2">Pathogenic</td></tr></tbody></table><table-wrap-foot><p>
<italic>NA</italic> not available</p></table-wrap-foot></table-wrap>
</p>
        </sec>
        <sec id="Sec5">
          <title>Patient 2, Family 2</title>
          <p>The proband (II:2, Fig.Â <xref rid="Fig1" ref-type="fig">1b</xref>) of family 2 is the second child of healthy first degree parents, born via normal vaginal delivery at 39Â weeks of gestation. He was initially evaluated in a local hospital for mild hypoglycemic attacks which were associated with jitteriness and irritability. He was first seen at our clinic at age of 2Â years. He was clinically normal, apart from an abnormal head tilt secondary to abnormal neck posturing. His height was -3SD and he had a stretched penile length of 0.5Â cm (â5.3 SD) with non-palpable testes. The patient had craniosynostosis causing plagiocephaly. Hypopituitarism was confirmed (TableÂ <xref rid="Tab1" ref-type="table">1</xref>). An MRI of his pituitary gland showed a small rudimentary adenohypophysis and a normal pituitary stalk present with normally placed neurohypophysis. A skeletal survey showed closure of sagittal suture causing dolichocephaly and thoracic scoliosis. L-thyroxine (50 mcg daily), hydrocortisone (2.5Â mg twice daily) and GH injections (0.035Â mg/kg/day) were initiated. Orchipexy was performed at the age of 2.5Â years. Testosterone therapy (25Â mg monthly) was given for 3Â months which improved penile length to 1.5Â cm. Two other testosterone courses were given at the age of 5Â years and 10Â years with a partial improvement in penile length to 3Â cm. Bilateral moderate SNHL was also found at the age of 3Â years. His growth improved in response to GH treatment; he had a growth velocity of 3â4Â cm per year. His height was 110Â cm at the age of 10Â years (â4SD). The prescribed dose for GH injections was 0.035Â mg/kg/day; however the patient was not compliant with treatment, which negatively affected the growth velocity and the ultimate height at the age of 10Â years.</p>
        </sec>
        <sec id="Sec6">
          <title>Patient 3, Family 2</title>
          <p>The younger sister (II:4, Fig.Â <xref rid="Fig1" ref-type="fig">1b</xref>) of the patient 2 was born via normal vaginal delivery at 39Â weeks of gestation. Her birth weight (2.9Â kg) and birth length (46Â cm) was adequate for gestational age. She also presented with jitteriness secondary to hypoglycemia at 2<sup>nd</sup> month of age and was suspected to have hypopituitarism (TableÂ <xref rid="Tab1" ref-type="table">1</xref>), because her older brother had been diagnosed with the same condition before. Treatment thyroxine, hydrocortisone and GH injections were started. She has moderate SNHL and a normal skeletal survey. Magnetic resonance imaging showed a normal pituitary gland. Clinical features and hormonal levels for all three affected patients are summarized in TableÂ <xref rid="Tab1" ref-type="table">1</xref>.</p>
        </sec>
      </sec>
      <sec id="Sec7">
        <title>Genetic analyses</title>
        <p>Genomic DNA extraction was carried out using PUREGENE DNA Extraction Kit according to manufacturerâs instructions (Gentra Systems, Minneapolis, MN) from the venous blood samples collected from each subject. All exons and adjacent exon-intron boundaries of the both <italic>LHX3</italic> transcripts were amplified in VeritiÂ® 96-Well Fast Thermal Cycler (Applied Biosystems, Foster City, CA) using HotStar Taq DNA Polymerase (Qiagen, Germantown, MD). Primers were designed by the use of Primer3 web based server (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/primer3/">http://frodo.wi.mit.edu/primer3/</ext-link>; sequences of primers used for PCR amplification are listed in TableÂ <xref rid="Tab2" ref-type="table">2</xref>). The PCR products were sequenced by dye termination sequencing using BigDyeÂ® Terminator Cycle Sequencing v3.1 Kit and ABI Prism 3730 Genetic Analyzer (Applied Biosystems, Inc., Foster City, CA, USA). Sequence analysis was performed using the SeqMan 6.1 module of the Lasergene (DNA Star Inc. WI, USA) software package and the results were compared with reference sequence. Accession numbers: Nucleotide and amino acid numbering are for <italic>LHX3</italic>, variant 2 (also known as isoform b) and correspond to NCBI reference sequence accession number NM_014564.3 for the cDNA and NP_055379.1 for the protein.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Sequences of oligonucleotide primers used for PCR amplification</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Primer</th><th>Sense Strand</th><th>Antisense Strand</th></tr></thead><tbody><tr><td>
<italic>LHX3</italic>_Exon 1a</td><td>5â²- CAACCCAGCCAGGGAG - 3â²</td><td>5â²- GTTTCCATCTCTGTGTCCCG - 3â²</td></tr><tr><td>
<italic>LHX3</italic>_ Exon 1b</td><td>5â²- CCCGGAGTCGCTTGGAC - 3â²</td><td>5â²- GCCCAGATCCTCTAGCTCC - 3â²</td></tr><tr><td>
<italic>LHX3</italic>_ Exon 2</td><td>5â²- CAGCCCTGAGTCCTGTGG - 3â²</td><td>5â²- TGATTGTGAGGGGAGGAGTC - 3â²</td></tr><tr><td>
<italic>LHX3</italic>_ Exon 3</td><td>5â²- CGGACAGAGCCTTCCTC - 3â²</td><td>5â²- GGAGAGAATTTCCCCGGAC - 3â²</td></tr><tr><td>
<italic>LHX3</italic>_ Exon 4â+â5</td><td>5â²- CTTCCGAGAAGCCTGTG - 3â²</td><td>5â²- TCCATGGGAAATTCAGATCC - 3â²</td></tr><tr><td>
<italic>LHX3</italic>_ Exon 6</td><td>5â²- CTGCAGGATGGGACTCTG - 3â²</td><td>5â²- CACCAGCCCTCCCTTGAC - 3â²</td></tr></tbody></table></table-wrap>
</p>
      </sec>
      <sec id="Sec8">
        <title>In silico prediction and pathogenicity assessment</title>
        <p>For interpretation of the identified sequence variants as per ACMG guidelines, PolyPhen2 (Polymorphism phenotyping; <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), SIFT (Sorting Intolerant From Tolerant; <ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>) and MutationTaster (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/">http://www.mutationtaster.org/</ext-link>) were used for pathogenicity assessment [<xref ref-type="bibr" rid="CR10">10</xref>]. Project HOPE ([<xref ref-type="bibr" rid="CR11">11</xref>]; <ext-link ext-link-type="uri" xlink:href="http://www.cmbi.ru.nl/hope/">http://www.cmbi.ru.nl/hope/</ext-link>) was used to predict the possible structural changes in the mutant protein using a normal LHX3 structure (PDB-file: 2JTN). The sequences form the <italic>Homo Sapiens</italic> LHX3 protein and homologous proteins from other eukaryotic species were obtained from the National Center for Biotechnology Information (NCBI; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>). A multiple alignment between these proteins was performed using Clustal Omega (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalo/">http://www.ebi.ac.uk/Tools/msa/clustalo/</ext-link>).</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Results</title>
      <p>Sanger sequencing of <italic>LHX3</italic> gene in the affected boy (II:2 from pedigree, Fig.Â <xref rid="Fig1" ref-type="fig">1a</xref>) from the first consanguineous family led us to the identification of a homozygous nucleotide change (c.437Gâ&gt;âT), resulting in a cysteine-to-phenylalanine substitution at 146 amino acid of the encoded protein (p. Cys146Phe) (Fig.Â <xref rid="Fig2" ref-type="fig">2a</xref>). In the two sibs (II:2 &amp; II:4 from pedigree, Fig.Â <xref rid="Fig1" ref-type="fig">1b</xref>) from the second family, we identified homozygosity for a single base exchange (c.466Câ&gt;âT). At the protein level, this transition predicts change of amino acid 156 from arginine to a stop codon (p. Arg156Ter) (Fig.Â <xref rid="Fig2" ref-type="fig">2b</xref>). Parents and siblings of the affected patients were all healthy and show no signs or symptoms related to the disorder. In addition, they were either heterozygous or wild type for the identified mutations (Fig.Â <xref rid="Fig1" ref-type="fig">1a and b</xref>). p. Cys146Phe is predicted to be âdamagingâ based on PolyPhen2, SIFT and MutationTaster. p. Arg156Ter is also predicted to be âdisease causingâ by MutationTaster. Both the alterations were not annotated in either dbSNP [<xref ref-type="bibr" rid="CR12">12</xref>], the 1000 Genomes Project database [<xref ref-type="bibr" rid="CR13">13</xref>], or Exome Aggregation Consortium (ExAC) [<xref ref-type="bibr" rid="CR14">14</xref>] and were absent in 400 normal chromosomes of ethnically matched controls, precluding that these represented benign or more common polymorphisms.<fig id="Fig2"><label>Fig. 2</label><caption><p>Identification of two novel mutations in <italic>LHX3</italic>. <bold>a</bold> Sequencing chromatogram indicating the homozygous wild type, heterozygous carrier and homozygous mutant forms. Homozygous c.437Â Gâ&gt;âT (p. Cys146Phe) mutation is identified in affected individual (II:2, family 1). <bold>b</bold> Homozygous c.466 Câ&gt;âT (p. Arg156Ter) mutation is identified in affected individuals (II:2 &amp; II:4, family 2). Nucleotide and amino acid numbering correspond to NM_014564.3 for the cDNA and NP_055379.1 for the protein. Nucleotides were numbered using A of the ATG translation initiation codon as +1 nucleotide of the coding sequence. Mutations are highlighted (<italic>arrow</italic>). <bold>c</bold> Ribbon/Cartoon-presentation of zinc finger motif of the LHX3 consisting of Î±-helix (<italic>green</italic>) and Î²-sheets (<italic>brown</italic>). The Zn binding residues of LIM domains are highly conserved; cysteine at position 146 (<italic>yellow</italic>) is a zinc ligating residue, involved in binding with the zinc cation (brown). <bold>d</bold> The multiple-sequence alignment was generated with the Clustal Omega Multiple Sequence Alignment tool and depicts conservation of the crucial p. Cys146 residue during evolution. <italic>Asterisk</italic> (*) indicates positions which have a single, fully conserved residue. <italic>Colon</italic> (:) indicates conservation between groups of strongly similar properties - scoringâ&gt;â0.5. <bold>e</bold>
<italic>LHX3</italic> mutations associated with combined pituitary hormone deficiency. Schematic representation of intron-exon structure of <italic>LHX3</italic> gene, domain graph of the encoded protein (Uniprot identifier: Q9UBR4), and the genetic variants. Exons are designated as <italic>boxes</italic> 1â6 and introns are shown by <italic>thin lines</italic>. A full-length wild type LHX3 protein is shown, with its N-terminus and C-terminus. Alternative splicing generates two isoforms, LHX3a and LHX3b, which are 397 and 402 amino acids long respectively. The isoforms differ only in the amino-terminal domains. Other known functional domains are following: LIM domains (LIM); homeodomain (HD), and carboxyl trans-activation domain (LSD). Novel variants identified in our study are <italic>boxed in red</italic> alongside previously reported variants in HGMD database [<xref ref-type="bibr" rid="CR28">28</xref>]. The mutations are grouped according to canonical classes and further identified by their amino acid changes</p></caption><graphic xlink:href="12902_2017_164_Fig2_HTML" id="MO2"/></fig>
</p>
      <p>The identified p. Cys146Phe substitution resides in the LIM2 domain of the LHX3 protein (Q9UBR4). LIM domain is recognized as a tandem zinc-finger (Znf) structure that functions as a modular protein-binding interface and LIM homeodomain proteins have been shown to play roles in cytoskeletal organization, organ development, cell adhesion, cell motility and signal transduction [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Znf motif mostly contain a pattern of cysteine and histidine residues that coordinately bind to zinc ions at the base of each of the two âfingersâ, but in some cases they bind other metals such as iron, or no metal at all [<xref ref-type="bibr" rid="CR17">17</xref>]. The cysteine at position 146 is a zinc ligating residue, involved in binding with the zinc cation (Fig.Â <xref rid="Fig2" ref-type="fig">2c</xref>). A three-dimensional-structure prediction analysis for p. Cys146Phe mutation by project HOPE predicts that the mutant residue (phenylalanine) will probably not fit in place of the smaller size wild-type cysteine residue which is buried in the core of the protein and will thus disturb the possible rearrangements of surrounding residues. In addition, the replacement of cysteine at p.146 will disrupt the putative interaction with zinc cation, thus affecting biological activity of LHX3. This cysteine is entirely conserved in LHX3 proteins in homologous sequences (Fig.Â <xref rid="Fig2" ref-type="fig">2d</xref>). It is part of the amino acid sequence âsignatureâ that defines the LIM domains proteins [<xref ref-type="bibr" rid="CR18">18</xref>], indicating that the Cys146 residue is critical to overall LHX3 function. The identified nonsense mutation p. Arg156Ter is predicted to result in a premature stop codon, loss of entire DNA-binding homeodomain and carboxyl terminus causing the production of short, inactive LHX3 protein or non-sense mediated decay of the aberrant mRNA. Mutant LHX3 proteins lacking a homeodomain do not bind DNA and thus do not induce transcription from pituitary genes. A complete loss of function is assumed with this homozygous mutation.</p>
      <p>Hence, the factors that p. Arg156Ter being a null variant and critical location of p. Cys146Phe in a well-established domain, their absence in population data/controls, computational evidence, segregation analysis and relevance to the patients phenotype, led us to classify these allelic variants; p. Arg156Ter and p. Cys146Phe as âpathogenicâ and âlikely pathogenicâ respectively, according to the recommendations of ACMG guidelines [<xref ref-type="bibr" rid="CR10">10</xref>] for the interpretation of sequence variants (see TableÂ <xref rid="Tab1" ref-type="table">1</xref>).</p>
    </sec>
    <sec id="Sec10" sec-type="conclusion">
      <title>Discussion and conclusions</title>
      <p>Pituitary organogenesis is a highly complex process and tightly regulated cascade of several transcription activators and repressors, and signaling molecules [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Anterior pituitary ontogenesis begins early around embryonic day (E) 7.5, corresponding to the first visualization of the pituitary placode. Briefly, during the early stage of pituitary development, which corresponds to E6.5-10.5 in mice, the extrinsic signaling pathways are activated, including bone morphogenetic protein (BMP2, BMP4), fibroblast growth factor (FGF8, 10 and 18), Sonic Hedgehog (SHH) and wingless (WNT4) pathways [<xref ref-type="bibr" rid="CR21">21</xref>]. Within the developing Rathkeâs pouch and anterior pituitary, a number of transcription factors are involved in a timely manner during the steps of differentiation; early acting such as paired homeodomain transcription factors (HESX1, PITX1, PITX2), LIM homeobox (LHX3, LHX4) or late-acting such as PROP1 (prophet of Pit-1) and POU1F1 (previously called PIT-1) [<xref ref-type="bibr" rid="CR22">22</xref>]. <italic>Lhx3</italic> gene expression is detected in the developing nervous system and Rathkeâs pouch at approximately E9 [<xref ref-type="bibr" rid="CR6">6</xref>]. By E12, POU1F1 synergistically partners with PITX1 and PITX2 for the differentiation of specific pituitary-specific cell types; thyrotropes, lactotropes and somatotropes [<xref ref-type="bibr" rid="CR23">23</xref>]. The gonadotrope and thyrotropic precursors are activated by zinc-finger transcription factor, GATA2 in response to inductive interaction of LHX3 and BMP2 signaling [<xref ref-type="bibr" rid="CR20">20</xref>]. Terminal differentiation of the pituitary completes at approximately E17 in response to the tightly controlled temporospatial gradient expression of transcription factor [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. A simplified scheme of expression of the transcription factors is given in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>. In <italic>Lhx3</italic> null mutant mice, Rathkeâs pouch is initially formed but then fails to grow resulting in either stillbirth or death shortly following birth, thus providing a genetic paradigm for the study of pituitary development [<xref ref-type="bibr" rid="CR25">25</xref>]. LHX3 is known to plays an essential role in the proper development of the spinal motoneurons (which likely explains neck rotation anomalies in human with <italic>LHX3</italic> mutation) and is also expressed in the auditory system [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Only a small number of studies have previously reported the clinical phenotype and genetic basis of <italic>LHX3</italic> patients (Human Gene Mutation Database [<xref ref-type="bibr" rid="CR28">28</xref>]). Together with two novel mutations identified in our study, there are now 16 different <italic>LHX3</italic> variants (Fig.Â <xref rid="Fig2" ref-type="fig">2e</xref>) in patients with CPHD3 phenotype as detailed in TableÂ <xref rid="Tab3" ref-type="table">3</xref>. The clinical phenotypes of human <italic>LHX3</italic> mutations encompass a varied presentation. The earliest descriptions of <italic>LHX3</italic> mutations were associated with panhypopituitarism without ACTH deficiency or any extrapituitary phenotypes [<xref ref-type="bibr" rid="CR29">29</xref>]. Later, a rigid cervical spine with limited head rotation, mental retardation and MRI findings of a hypodense lesion in the pituitary was also reported in addition to CPHD [<xref ref-type="bibr" rid="CR30">30</xref>]. Four homozygous <italic>LHX3</italic> mutations with CPHD, with or without limited neck rotation were identified in a cohort of 366 patients with hypopituitarism or CPHD. Hearing status in these patients was not documented to be either normal or with any hearing deficit [<xref ref-type="bibr" rid="CR31">31</xref>]. Bilateral SNHL was first associated as an additional CPHD3 phenotype in the four patients with CPHD, severe pituitary hypoplasia, ACTH deficiency and skeletal abnormalities [<xref ref-type="bibr" rid="CR32">32</xref>]. The occurrence of SNHL was explained by expression of <italic>LHX3</italic> in a pattern overlapping that of <italic>SOX2</italic> in the sensory epithelium of developing inner ear [<xref ref-type="bibr" rid="CR32">32</xref>]. Later, six patients from a same genealogy with CPHD, restricted neck rotation, scoliosis and congenital hearing impairment were described to harbor a recessive novel splice acceptor site mutation [<xref ref-type="bibr" rid="CR33">33</xref>]. More recently, a complete loss of function mutation is associated with CPHD including ACTH deficiency, short neck and SNHL [<xref ref-type="bibr" rid="CR5">5</xref>]. Compound heterozygous <italic>LHX3</italic> defects in a nonconsanguineous patient with syndromic CPHD, severe scoliosis and normal intelligence and a novel homozygous mutation p.T194R were recently reported [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>A simplified scheme of the development cascade representing the main transcription factors expression during pituitary development (adapted from de Moraes et al. [<xref ref-type="bibr" rid="CR20">20</xref>]). Pituitary cell lineages are determined by the activation or repression of each transcription factor. LHX3 participates in the pituitary cell differentiation and maturation process. The anterior pituitary consists of five distinct cell types. These cells and their specific hormones are lactotropes, which produce PRL; somatotropes, which produce GH; gonadotropes, which produce LH and FSH; corticotropes, which produce ACTH; and thyrotropes, which produce TSH. Any mutation that alters the length, quality or quantity of any gene involved in the development cascade will result in pituitary development failure</p></caption><graphic xlink:href="12902_2017_164_Fig3_HTML" id="MO3"/></fig>
<table-wrap id="Tab3"><label>Table 3</label><caption><p>
<italic>LHX3</italic> mutations in patients with CPHD3 phenotype</p></caption><table frame="hsides" rules="groups"><thead><tr><th>No.</th><th>Mutation</th><th>Amino acid change</th><th>Mutation Type</th><th colspan="2">Reference</th></tr><tr><th colspan="4"/><th>Authors</th><th>Journal [Reference No]</th></tr></thead><tbody><tr><td>1</td><td>c.148Aâ&gt;âT</td><td>Lys50Ter</td><td>Nonsense</td><td>Rajab A et al.</td><td>Hum Mol Genet 2008 [<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td>2</td><td>c.229Câ&gt;âT</td><td>Arg77Ter</td><td>Nonsense</td><td>Bonfig W et al.</td><td>Eur J Pediatr 2011 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td>3</td><td>c.347Aâ&gt;âG</td><td>Tyr116Cys</td><td>Missense</td><td>Netchine I et al.</td><td>Nat Genet 2000 [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>4</td><td>c.368Gâ&gt;âA</td><td>Cys123Tyr</td><td>Missense</td><td>Sobrier M et al.</td><td>J Clin Endocrinol Metab 2012 [<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td>5</td><td>c.437Gâ&gt;âT</td><td>Cys146Phe</td><td>Missense</td><td>Ramzan K et al.</td><td>BMC Endocr Disord</td></tr><tr><td>6</td><td>c.466Câ&gt;âT</td><td>Arg156Ter</td><td>Nonsense</td><td>Ramzan K et al.</td><td>BMC Endocr Disord</td></tr><tr><td>7</td><td>c.581Aâ&gt;âG</td><td>Gln194Arg</td><td>Missense</td><td>Bechtold-Dalla Pozza S et al.</td><td>Horm Res Paediatr 2012 [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td>8</td><td>c.644Câ&gt;âT</td><td>Ala215Val</td><td>Missense</td><td>Pfaeffle R et al.</td><td>J Clin Endocrinol Metab 2007 [<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>9</td><td>c.687Gâ&gt;âA</td><td>Trp229Ter</td><td>Nonsense</td><td>Pfaeffle R et al.</td><td>J Clin Endocrinol Metab 2007 [<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>10</td><td>c.267-3Câ&gt;âG</td><td/><td>Splicing</td><td>Sobrier M et al.</td><td>J Clin Endocrinol Metab 2012 [<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td>11</td><td>c.470-2 Aâ&gt;âG</td><td/><td>Splicing</td><td>Kristrom B et al.</td><td>J Clin Endocrinol Metab 2009 [<xref ref-type="bibr" rid="CR33">33</xref>]</td></tr><tr><td>12</td><td>c.111delT</td><td>Gly38Alafs*140</td><td>Deletion</td><td>Bhangoo A et al.</td><td>J Clin Endocrinol Metab 2006 [<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td>13</td><td>c.302_303delG CinsTCCT</td><td>Gly101Valfs*78</td><td>Small indel</td><td>Pfaeffle R et al.</td><td>J Clin Endocrinol Metab 2007 [<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>14</td><td>&lt;1.4Â Mb incl. entire gene</td><td/><td>Gross deletion</td><td>Pfaeffle R et al.</td><td>J Clin Endocrinol Metab 2007 [<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>15</td><td>23Â bp E3I3-3 to E3I3â+â20</td><td/><td>Gross deletion</td><td>Netchine I et al.</td><td>Nat Genet 2000 [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>16</td><td>3088Â bp incl. ex. 2-5</td><td/><td>Gross deletion</td><td>Rajab A et al.</td><td>Hum Mol Genet 2008 [<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr></tbody></table><table-wrap-foot><p>Nucleotide and amino acid numbering are based on <italic>LHX3</italic>, variant 2 (also known as isoform b) and correspond to NCBI reference sequence accession number NM_014564.3 for the cDNA and NP_055379.1 for the protein. Nucleotide numbering commenced with the A of the ATG translation initiation codon as +1</p></table-wrap-foot></table-wrap>
</p>
      <p>A candidate-gene approach was used on the basis of documented pituitary abnormalities, restricted neck rotation and SNHL, <italic>LHX3</italic> gene was then sequenced. Herein, we characterize two novel mutations in three patients from two unrelated Saudi consanguineous families. The three patients presented with early infantile hypoglycemia and deficiency of all anterior pituitary hormones including ACTH. Two of the affected patients also displayed rigidity of the cervical spine and short neck with limited rotation. Clinically, there was no evidence of cardiac defects or skin manifestations as reported earlier in some reports [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Birth length in one of our patients was slightly below the mean centile for gestational age, which supports earlier findings that IGFs are necessary for that period but the severe deficiency interacts with intrauterine longitudinal growth [<xref ref-type="bibr" rid="CR33">33</xref>]. Hearing impairment was noticed for all three affected at the age of 2â3 years, audiologic assessment later confirmed moderate SNHL that was partially managed with hearing aids and all had receptive and expressive language delay. Perinatal mortality has been reported in other families with <italic>LHX3</italic> mutations; our study family 1 had a baby girl who died at an early age probably due to the similar phenotype. Both the male patients had markedly delayed pubertal development and micropenis symptom, which can thus facilitate the diagnosis in case of a male child. Short neck and neonatal hypoglycemia may be overlooked in neonatal cases, but the prolonged jaundice and hypothyroidism should lead to the diagnosis of CPHD.</p>
      <p>The incidence of reported mutations in <italic>LHX3</italic> gene remains low. Clinical, hormonal and radiological work-up is very important to better determine which transcription factor should be screened. We suggest that the presence of SNHL and limited neck rotation be considered in the differential diagnosis of CPHD3 to facilitate molecular diagnosis. The identification of a <italic>LHX3</italic> mutation at an early age is likely to be beneficial for patients to start an appropriate replacement of hormone deficiencies, auditory testing to allow regular speech development, counseling for limitations of cervical mobility and development of scoliosis, and for continual monitoring of these patients. The importance to characterize the patients with CPHD should be emphasized to physicians and researchers to help the genetic screening of patients, and to assist genetic counseling and prenatal diagnosis.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ACTH</term>
          <def>
            <p>Adrenocorticotrophic hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>CPHD</term>
          <def>
            <p>Combined pituitary hormone deficiency</p>
          </def>
        </def-item>
        <def-item>
          <term>FSH</term>
          <def>
            <p>Follicular stimulating hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>FT4</term>
          <def>
            <p>Free thyroxine</p>
          </def>
        </def-item>
        <def-item>
          <term>GH</term>
          <def>
            <p>Growth hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>IGF1</term>
          <def>
            <p>Insulin growth factor 1</p>
          </def>
        </def-item>
        <def-item>
          <term>IGFBP3</term>
          <def>
            <p>Insulin growth factor binding protein 3</p>
          </def>
        </def-item>
        <def-item>
          <term>LH</term>
          <def>
            <p>Leutinizing hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>LIM-HD</term>
          <def>
            <p>LIM-homeodomain</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>Magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>PRL</term>
          <def>
            <p>Prolactin</p>
          </def>
        </def-item>
        <def-item>
          <term>SNHL</term>
          <def>
            <p>Sensorineural hearing loss</p>
          </def>
        </def-item>
        <def-item>
          <term>TSH</term>
          <def>
            <p>Thyroid stimulating hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>Znf</term>
          <def>
            <p>Zinc-finger</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Acknowledgement</title>
      <p>The authors thank patients and their families for their participation. We also thank the sequencing core facilities for their technical help.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>This work was funded and supported in part by King Faisal Specialist Hospital and Research Centre (RAC#2100001) and the King Salman Centre for Disability Research (KSCDR #85722).</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>All data contained within the article.</p>
      </sec>
      <sec id="FPar3">
        <title>Authorsâ contributions</title>
        <p>KR was primarily responsible for the molecular genetic studies, data interpretation, drafting and finalizing the manuscript; BB and MO were primarily responsible for clinical support, clinical evaluation and sample collection; BB and MO also participated in editing of the manuscript; RA assisted in carrying out molecular genetic studies; LA coordinated the study. FI provided oversight for the project and final editing of the manuscript. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the all the family members for publication of this case report and any accompanying images. Parents provided consent to publish on behalf o all minors. A copy of the written consent is available for review by the Editor of this journal.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>Approval for this study was obtained from the KFSH &amp; RC ethics committee (RAC#2100 001). All family members gave informed written consent to participate in the genetic test. Parents provided the informed consent for participation of patients 1, 2 and 3 and all other siblings who are minor.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelberman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dattani</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Hypothalamic and pituitary development: novel insights into the aetiology</article-title>
          <source>Eur J Endocrinol</source>
          <year>2007</year>
          <volume>157</volume>
          <issue>Suppl 1</issue>
          <fpage>3</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1530/EJE-07-0156</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diaczok</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zunich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Radovick</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2009</year>
          <volume>93</volume>
          <fpage>4351</fpage>
          <lpage>4358</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2008-1189</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romero</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Pine-Twaddell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Radovick</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations associated with combined pituitary hormone deficiency</article-title>
          <source>J Mol Endocrinol</source>
          <year>2011</year>
          <volume>46</volume>
          <fpage>R93</fpage>
          <lpage>R102</lpage>
          <pub-id pub-id-type="doi">10.1530/JME-10-0133</pub-id>
          <?supplied-pmid 21447626?>
          <pub-id pub-id-type="pmid">21447626</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelberman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dattani</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism</article-title>
          <source>Ann Med</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>560</fpage>
          <lpage>577</lpage>
          <pub-id pub-id-type="doi">10.1080/07853890600994963</pub-id>
          <?supplied-pmid 17438671?>
          <pub-id pub-id-type="pmid">17438671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonfig</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Krude</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature</article-title>
          <source>Eur J Pediatr</source>
          <year>2011</year>
          <volume>170</volume>
          <fpage>1017</fpage>
          <lpage>1021</lpage>
          <pub-id pub-id-type="doi">10.1007/s00431-011-1393-x</pub-id>
          <?supplied-pmid 21249393?>
          <pub-id pub-id-type="pmid">21249393</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bach</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Pearse</surname>
              <given-names>RV</given-names>
              <suffix>2nd</suffix>
            </name>
            <name>
              <surname>Heinzel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gloss</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Scully</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Sawchenko</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1995</year>
          <volume>92</volume>
          <fpage>2720</fpage>
          <lpage>2724</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.92.7.2720</pub-id>
          <?supplied-pmid 7708713?>
          <pub-id pub-id-type="pmid">7708713</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sloop</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Bridwell</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Schiller</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Differential activation of pituitary hormone genes by human Lhx3 isoforms with distinct DNA binding properties</article-title>
          <source>Mol Endocrinol</source>
          <year>1999</year>
          <volume>13</volume>
          <fpage>2212</fpage>
          <lpage>2225</lpage>
          <pub-id pub-id-type="doi">10.1210/mend.13.12.0395</pub-id>
          <?supplied-pmid 10598593?>
          <pub-id pub-id-type="pmid">10598593</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>West</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Savage</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Kiratipranon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Toomey</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Beach</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Colvin</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Sloop</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the follicle-stimulating hormone beta gene by the LHX3 LIM-homeodomain transcription factor</article-title>
          <source>Endocrinology</source>
          <year>2004</year>
          <volume>145</volume>
          <fpage>4866</fpage>
          <lpage>4879</lpage>
          <pub-id pub-id-type="doi">10.1210/en.2004-0598</pub-id>
          <?supplied-pmid 15271874?>
          <pub-id pub-id-type="pmid">15271874</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhary</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bano</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Imaging of pediatric pituitary endocrinopathies</article-title>
          <source>Indian J Endocrinol Metab</source>
          <year>2012</year>
          <volume>16</volume>
          <fpage>682</fpage>
          <lpage>691</lpage>
          <pub-id pub-id-type="doi">10.4103/2230-8210.100635</pub-id>
          <?supplied-pmid 23087850?>
          <pub-id pub-id-type="pmid">23087850</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richards</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bale</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bick</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gastier-Foster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Grody</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Hegde</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Spector</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Voelkerding</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rehm</surname>
              <given-names>HL</given-names>
            </name>
            <collab>ACMG Laboratory Quality Assurance Committee</collab>
          </person-group>
          <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>
          <source>Genet Med</source>
          <year>2015</year>
          <volume>17</volume>
          <fpage>405</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
          <?supplied-pmid 25741868?>
          <pub-id pub-id-type="pmid">25741868</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venselaar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Te Beek</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Kuipers</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Hekkelman</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Vriend</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces</article-title>
          <source>BMC Bioinf</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>548</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-11-548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Database of Single Nucleotide Polymorphisms (dbSNP). Bethesda: National Center for Biotechnology Information, National Library of Medicine; (dbSNP Build ID: 138). <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>. Accessed 14 Feb 2017.</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="other">1000 Genome projects. <ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org/">http://browser.1000genomes.org/</ext-link>. Accessed 14 Feb 2017.</mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="other">Exome Aggregation Consortium (ExAC). <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>. Accessed 14 Feb 2017.</mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nancarrow</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Bach</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Guss</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes</article-title>
          <source>EMBO J</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>2018</fpage>
          <lpage>2029</lpage>
          <pub-id pub-id-type="doi">10.1038/emboj.2008.123</pub-id>
          <?supplied-pmid 18583962?>
          <pub-id pub-id-type="pmid">18583962</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matthews</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bhati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lehtomaki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mansfield</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Cubeddu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>It takes two to tango: the structure and function of LIM, RING, PHD and MYND domains</article-title>
          <source>Curr Pharm Des</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>3681</fpage>
          <lpage>3696</lpage>
          <pub-id pub-id-type="doi">10.2174/138161209789271861</pub-id>
          <?supplied-pmid 19925420?>
          <pub-id pub-id-type="pmid">19925420</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perez-Alvarado</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Michelsen</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Louis</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Winge</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Beckerle</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Summers</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP</article-title>
          <source>Nat Struct Biol</source>
          <year>1994</year>
          <volume>1</volume>
          <fpage>388</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="doi">10.1038/nsb0694-388</pub-id>
          <?supplied-pmid 7664053?>
          <pub-id pub-id-type="pmid">7664053</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kadrmas</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Beckerle</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>The LIM domain: from the cytoskeleton to the nucleus</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>920</fpage>
          <lpage>931</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm1499</pub-id>
          <?supplied-pmid 15520811?>
          <pub-id pub-id-type="pmid">15520811</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prince</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Walvoord</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>The role of homeodomain transcription factors in heritable pituitary disease</article-title>
          <source>Nat Rev Endocrinol</source>
          <year>2011</year>
          <volume>7</volume>
          <fpage>727</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="doi">10.1038/nrendo.2011.119</pub-id>
          <?supplied-pmid 21788968?>
          <pub-id pub-id-type="pmid">21788968</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Moraes</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Vaisman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Conceicao</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Ortiga-Carvalho</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors</article-title>
          <source>J Endocrinol</source>
          <year>2012</year>
          <volume>215</volume>
          <fpage>239</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="doi">10.1530/JOE-12-0229</pub-id>
          <?supplied-pmid 22872762?>
          <pub-id pub-id-type="pmid">22872762</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gleiberman</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Fedtsova</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Tissue interactions in the induction of anterior pituitary: role of the ventral diencephalon, mesenchyme, and notochord</article-title>
          <source>Dev Biol</source>
          <year>1999</year>
          <volume>213</volume>
          <fpage>340</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="doi">10.1006/dbio.1999.9386</pub-id>
          <?supplied-pmid 10479452?>
          <pub-id pub-id-type="pmid">10479452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dattani</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter?</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2005</year>
          <volume>63</volume>
          <fpage>121</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2265.2005.02289.x</pub-id>
          <pub-id pub-id-type="pmid">16060904</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simmons</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Voss</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Ingraham</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Holloway</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Broide</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Rosenfeld</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Swanson</surname>
              <given-names>LW</given-names>
            </name>
          </person-group>
          <article-title>Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors</article-title>
          <source>Genes Dev</source>
          <year>1990</year>
          <volume>4</volume>
          <fpage>695</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.4.5.695</pub-id>
          <?supplied-pmid 2379827?>
          <pub-id pub-id-type="pmid">2379827</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seidah</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Barale</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Marcinkiewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mattei</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>ChrÃ©tien</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The mouse homeoprotein mLIM-3 is expressed early in cells derived from the neuroepithelium and persists in adult pituitary</article-title>
          <source>DNA Cell Biol</source>
          <year>1994</year>
          <volume>13</volume>
          <fpage>1163</fpage>
          <lpage>1180</lpage>
          <pub-id pub-id-type="doi">10.1089/dna.1994.13.1163</pub-id>
          <?supplied-pmid 7811383?>
          <pub-id pub-id-type="pmid">7811383</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheng</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Zhadanov</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Mosinger</surname>
              <given-names>B</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bertuzzi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grinberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Mahon</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Westphal</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Specification of pituitary cell lineages by the LIM homeobox gene Lhx3</article-title>
          <source>Science</source>
          <year>1996</year>
          <volume>272</volume>
          <fpage>1004</fpage>
          <lpage>1007</lpage>
          <pub-id pub-id-type="doi">10.1126/science.272.5264.1004</pub-id>
          <?supplied-pmid 8638120?>
          <pub-id pub-id-type="pmid">8638120</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuchida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ensini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Baldassare</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jessell</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Pfaff</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes</article-title>
          <source>Cell</source>
          <year>1994</year>
          <volume>79</volume>
          <fpage>957</fpage>
          <lpage>970</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(94)90027-2</pub-id>
          <?supplied-pmid 7528105?>
          <pub-id pub-id-type="pmid">7528105</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>HZ</given-names>
            </name>
            <name>
              <surname>Lettieri</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karavanov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Potter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Westphal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pfaff</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons</article-title>
          <source>Cell</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>817</fpage>
          <lpage>828</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81704-3</pub-id>
          <?supplied-pmid 9865699?>
          <pub-id pub-id-type="pmid">9865699</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="other">The Human Gene Mutation Database, <ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/">http://www.hgmd.cf.ac.uk</ext-link>. Accessed 14 Feb 2017.</mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Netchine</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sobrier</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Krude</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schnabel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Maghnie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marcos</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Duriez</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cacheux</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Moers</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Goossens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>GrÃ¼ters</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amselem</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency</article-title>
          <source>Nat Genet</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>182</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="doi">10.1038/76041</pub-id>
          <?supplied-pmid 10835633?>
          <pub-id pub-id-type="pmid">10835633</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhangoo</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Savage</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Anhalt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pavlakis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walvoord</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Ten</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2006</year>
          <volume>91</volume>
          <fpage>747</fpage>
          <lpage>753</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2005-2360</pub-id>
          <?supplied-pmid 16394081?>
          <pub-id pub-id-type="pmid">16394081</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfaeffle</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Savage</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Palme</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ahlmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bellone</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schoenau</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Korsch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>BrÃ¤mswig</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Stobbe</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Blum</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2007</year>
          <volume>92</volume>
          <fpage>1909</fpage>
          <lpage>1919</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2006-2177</pub-id>
          <?supplied-pmid 17327381?>
          <pub-id pub-id-type="pmid">17327381</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajab</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kelberman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>de Castro</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Biebermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shaikh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Shaikh</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gerrelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Grueters</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Krude</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dattani</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss</article-title>
          <source>Hum Mol Genet</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>2150</fpage>
          <lpage>2159</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddn114</pub-id>
          <?supplied-pmid 18407919?>
          <pub-id pub-id-type="pmid">18407919</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kristrom</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zdunek</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rydh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jonsson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sehlin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Escher</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2009</year>
          <volume>94</volume>
          <fpage>1154</fpage>
          <lpage>1161</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2008-0325</pub-id>
          <?supplied-pmid 19126629?>
          <pub-id pub-id-type="pmid">19126629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bechtold-Dalla Pozza</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hiedl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roeb</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lohse</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>DurÃ¡n-Prado</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency</article-title>
          <source>Horm Res Paediatr</source>
          <year>2012</year>
          <volume>77</volume>
          <fpage>41</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1159/000335929</pub-id>
          <?supplied-pmid 22286346?>
          <pub-id pub-id-type="pmid">22286346</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sobrier</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Brachet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vie-Luton</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Copin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Legendre</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heinrichs</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Amselem</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Symptomatic heterozygotes and prenatal diagnoses in a nonconsanguineous family with syndromic combined pituitary hormone deficiency resulting from two novel LHX3 mutations</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2012</year>
          <volume>97</volume>
          <fpage>E503</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2011-2095</pub-id>
          <?supplied-pmid 22238406?>
          <pub-id pub-id-type="pmid">22238406</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>